Package 68382-556-30

Brand: carbamazepine

Generic: carbamazepine
NDC Package

Package Facts

Identity

Package NDC 68382-556-30
Digits Only 6838255630
Product NDC 68382-556
Description

10 BLISTER PACK in 1 CARTON (68382-556-30) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2019-03-12
Brand carbamazepine
Generic carbamazepine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1d3f1616-667b-4e79-aa22-35bf35c4c108", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["199378", "402505", "402506"], "spl_set_id": ["c5e4a25a-0137-4327-96f5-15735891ad5c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals (USA) Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-556-01)", "package_ndc": "68382-556-01", "marketing_start_date": "20190312"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-556-06)", "package_ndc": "68382-556-06", "marketing_start_date": "20190312"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-556-16)", "package_ndc": "68382-556-16", "marketing_start_date": "20190312"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (68382-556-30)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "68382-556-30", "marketing_start_date": "20190312"}], "brand_name": "carbamazepine", "product_id": "68382-556_1d3f1616-667b-4e79-aa22-35bf35c4c108", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "68382-556", "generic_name": "carbamazepine", "labeler_name": "Zydus Pharmaceuticals (USA) Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA205571", "marketing_category": "ANDA", "marketing_start_date": "20190312", "listing_expiration_date": "20261231"}